Health Canada's Progressive Licensing Framework

Yeates, Neil; Lee, David K.; Maher, Maurica
June 2007
CMAJ: Canadian Medical Association Journal;6/19/2007, Vol. 176 Issue 13, p1845
Academic Journal
The article discusses the concepts governing the establishment of the new Progressive Licensing Framework, a new framework composing of laws, guidelines and regulations which will support the timely access to drugs and provide a mechanism for continuous reassessment and monitoring of a drug's quality, safety and effectiveness in Canada. Health Canada's framework will adopt evidence-based decision making, a life-cycle approach, good planning and accountability.


Related Articles

  • Waits for Access to New Biological and Pharmaceutical Medicines: Evidence of Government Failure. Skinner, Brett J.; Rovere, Mark // Fraser Forum;Jun2007, p7 

    The article presents the evidences of the delayed approval of drugs by the federal government in Canada. According to a study, provincial officials wait longer to make such drugs eligible despite being declared safe and effective by Health Canada due to differences involving the kind of drugs...

  • Pharmacogenomics guidance from Health Canada.  // WHO Drug Information;2007, Vol. 21 Issue 3, p245 

    The article reports that Health Canada has released the final version of the regulatory guidance Submission of Pharmacogenomic Information. It cited that the document provides guidance to sponsors on how and when to submit pharmacogenomic information to the company. It cited that it also...

  • Ottawa passes drug safety law. Eggertson, Laura // CMAJ: Canadian Medical Association Journal;8/5/2014, Vol. 186 Issue 11, p818 

    The article reports that Ottawa's House of Commons approved the Bill C-17, a drug safety law which amends the Food and Drugs Act. Topics discussed include the law to give authority to the minister of health to order a drug off the market if surveillance data showed a serious risk, authority for...

  • Patients Waiting Too Long for Government Permission to Use New Drugs in Canada. Skinner, Brett J. // Fraser Forum;Jun2007, p4 

    The article focuses on the delayed approval of drugs by the federal government in Canada. A study revealed that such delay took 491 days on average in 2005, which is believed to cause the patients to lose potential health benefits as they wait until such drugs are approved safe and effective to...

  • CODEX ALIMENTARIUS.  // American Herb Association Quarterly Newsletter;Spring2005, Vol. 20 Issue 4, p7 

    Focuses on issues regarding the use of the Codex, a guideline for European states that classifies vitamin and mineral food supplements. Controversies behind the adoption of the Codex; Effort of the U.S. to work against the infiltration of the guideline; Confusion between Codex and the European...

  • R.I. law for Canadian drug importation may fail.  // Drug Store News;11/22/2004, Vol. 26 Issue 16, p10 

    Focuses on the law supporting Canadian drug importation. Controversies behind the law.

  • Key Hatch-Waxman reforms per MMA legislation.  // Drug Store News;11/22/2004, Vol. 26 Issue 16, p30 

    Provides information about the Key Hatch-Waxman reforms according to the Medicare Prescription Drug Improvement and Modernization Act. Rules for filing an abbreviated new drug application; Terms for holder of a new drug application; Conditions for any abbreviated new drug application submitted.

  • Paracetamol availability and recent changes in paracetamol poisoning: is the 1998 legislation limiting availability of paracetamol being followed? Greene, S. L.; Dargan, P. I.; Leman, P.; Jones, A. L. // Postgraduate Medical Journal;Aug2006, Vol. 82 Issue 970, p520 

    Objective: To determine the degree of adherence to legislation introduced in 1998 restricting the availability of over the counter paracetamol. Design: A prospective observational study. Setting: An emergency department in an inner city London teaching hospital. Pharmacy and non-pharmacy outlets...

  • Survey: confusion prevails over cards.  // Drug Store News;8/23/2004, Vol. 26 Issue 10, p1 

    Reports on the confusion over the Medicare drug discount card program among beneficiaries. Percentage of Medicare recipients who do not understand the Medicare Modernization Act; Opinion of respondents on the Medicare law that allows recipients to choose the best plan for them; Comparison of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics